tiprankstipranks
Fairfax India SV USF (TSE:FIH.U)
TSX:FIH.U
Want to see TSE:FIH.U full AI Analyst Report?

Fairfax India SV USF (FIH.U) AI Stock Analysis

40 Followers

Top Page

TSE:FIH.U

Fairfax India SV USF

(TSX:FIH.U)

Select Model
Select Model
Select Model
Neutral 54 (OpenAI - 5.2)
Rating:54Neutral
Price Target:
Action:Reiterated
Date:05/09/26
The score is held back primarily by weak cash flow durability (negative operating and free cash flow across multiple periods) and volatile operating results, despite a conservatively positioned balance sheet with low leverage. Valuation is difficult to assess with a negative P/E and no dividend yield, and technical signals were not available from the provided data.
Positive Factors
India‑focused long‑term holding vehicle
The firm’s mandate as an India‑focused holding company managed by Fairfax supports a patient‑capital strategy across sectors. That structural positioning enables long‑term ownership, alignment with multi‑year India growth trends and the ability to ride out short‑term market swings to compound value.
Negative Factors
Sustained negative operating and free cash flow
Multi‑period negative operating and free cash flow indicates earnings have not converted to cash recently, creating a structural cash‑generation shortfall. That reduces internal funding for new investments or distributions, increases reliance on asset sales or external financing, and weakens liquidity resilience over months.
Read all positive and negative factors
Positive Factors
Negative Factors
India‑focused long‑term holding vehicle
The firm’s mandate as an India‑focused holding company managed by Fairfax supports a patient‑capital strategy across sectors. That structural positioning enables long‑term ownership, alignment with multi‑year India growth trends and the ability to ride out short‑term market swings to compound value.
Read all positive factors

Fairfax India SV USF (FIH.U) vs. iShares MSCI Canada ETF (EWC)

Fairfax India SV USF Business Overview & Revenue Model

Company Description
Fairfax India Holdings Corporation, an investment holding company, engages in the investment activities in India. It invests in public and private equity securities and debt instruments in India and Indian businesses, or other businesses with cust...
How the Company Makes Money
The company primarily makes money through investment returns generated by its portfolio of Indian holdings. Key earnings drivers typically include (1) dividends and other distributions received from portfolio companies, (2) realized gains when it ...

Fairfax India SV USF Financial Statement Overview

Summary
Balance sheet strength and low leverage support financial resilience, and profitability is positive in 2025 and 2026 TTM. However, results are volatile (including a 2024 net loss and sharp revenue swings), and the biggest issue is cash flow quality: operating cash flow and free cash flow are negative across 2024, 2025, and 2026 TTM, indicating weak cash conversion and a multi-period cash burn.
Income Statement
62
Positive
Balance Sheet
78
Positive
Cash Flow
34
Negative
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue67.78M111.14M59.65M490.09M234.97M567.57M
Gross Profit34.37M68.24M34.65M465.09M209.97M542.26M
EBITDA385.67M568.73M26.21M451.90M195.97M533.53M
Net Income256.18M417.71M-41.17M371.77M191.44M494.51M
Balance Sheet
Total Assets3.49B4.04B3.63B3.82B3.37B3.58B
Cash, Cash Equivalents and Short-Term Investments25.58M8.10M59.32M174.62M147.45M30.38M
Total Debt499.00M497.96M498.35M497.83M497.31M496.79M
Total Liabilities772.00M813.46M673.52M736.76M608.80M681.91M
Stockholders Equity2.56B3.07B2.83B2.96B2.64B2.77B
Cash Flow
Free Cash Flow-31.07M-31.66M-103.44M66.61M152.34M61.09M
Operating Cash Flow-31.07M-31.66M-103.44M66.61M152.34M61.09M
Investing Cash Flow48.54M-9.18M0.000.000.000.00
Financing Cash Flow-12.05M-10.62M-8.42M-37.25M-35.58M-51.30M

Fairfax India SV USF Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
C$944.20M2.1821.69%-3.24%
74
Outperform
C$358.29M3.6813.92%1.47%-114.77%79.72%
72
Outperform
C$358.29M3.6813.92%1.43%-114.77%79.72%
71
Outperform
C$1.03B14.785.72%0.14%-57.36%-41.04%
69
Neutral
C$1.13B9.559.72%3.01%4.44%18.34%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
54
Neutral
9.501.97%-30.13%783.37%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:FIH.U
Fairfax India SV USF
TSE:URB.A
Urbana
8.42
2.21
35.65%
TSE:AGF.B
AGF Management B NV
17.18
5.52
47.34%
TSE:CVG
Clairvest
75.73
4.56
6.41%
TSE:SEC
Senvest Capital
390.00
89.53
29.80%
TSE:URB
Urbana Corporation
9.29
3.08
49.57%

Fairfax India SV USF Corporate Events

Business Operations and StrategyM&A Transactions
Fairfax India Exits Stake in Sanmar Chemical for US$27 Million
Neutral
Apr 9, 2026
Fairfax India Holdings Corporation has exited its investment in Sanmar Chemical Enterprises Limited by selling its entire holding of 1,742,987 equity shares through its wholly owned subsidiary, FIH Mauritius Investments Ltd. The shares were sold t...
Business Operations and StrategyShareholder Meetings
Fairfax India Sets Hybrid AGM to Deepen Investor Engagement
Positive
Apr 6, 2026
Fairfax India Holdings Corporation, a Toronto-listed investment holding company focused on Indian public and private equities and debt, is structured to generate long-term capital growth while preserving investor capital. The firm concentrates on ...
Business Operations and StrategyStock BuybackFinancial DisclosuresPrivate Placements and Financing
Fairfax India Swings to Profit on Strong Investment Gains and Expands Indian Portfolio
Positive
Feb 20, 2026
Fairfax India reported a sharp turnaround for 2025, posting net earnings of $410.5 million, or $3.05 per diluted share, versus a loss a year earlier, as book value per share rose 9.4% to $22.94 on strong gains from key Indian investments. Results ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 09, 2026